X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18259) 18259
Newsletter (36) 36
Newspaper Article (30) 30
Magazine Article (16) 16
Book / eBook (15) 15
Book Chapter (3) 3
Book Review (2) 2
Conference Proceeding (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16279) 16279
male (8775) 8775
female (8302) 8302
middle aged (6594) 6594
oncology (6185) 6185
liver cancer (6029) 6029
hepatocellular carcinoma (5714) 5714
cancer (5624) 5624
animals (4983) 4983
liver (4919) 4919
liver neoplasms - virology (4793) 4793
aged (4696) 4696
adult (4666) 4666
liver neoplasms - pathology (4386) 4386
carcinoma, hepatocellular - virology (4357) 4357
carcinoma, hepatocellular - pathology (3683) 3683
gastroenterology & hepatology (3444) 3444
tumors (3331) 3331
mice (3223) 3223
medicine (3151) 3151
research article (3086) 3086
liver neoplasms - genetics (3064) 3064
cell line, tumor (2906) 2906
hepatoma (2874) 2874
carcinoma, hepatocellular - genetics (2750) 2750
risk factors (2746) 2746
expression (2712) 2712
multidisciplinary sciences (2689) 2689
science (2640) 2640
liver neoplasms - metabolism (2478) 2478
gene expression (2466) 2466
health aspects (2457) 2457
proteins (2410) 2410
hepatocellular-carcinoma (2395) 2395
metastasis (2375) 2375
hepatitis (2354) 2354
prognosis (2337) 2337
carcinoma, hepatocellular - metabolism (2186) 2186
apoptosis (2154) 2154
analysis (2146) 2146
research (2097) 2097
patients (1933) 1933
hepatitis b virus (1830) 1830
surgery (1795) 1795
survival (1748) 1748
cirrhosis (1739) 1739
digestive system diseases (1721) 1721
liver diseases (1709) 1709
cell biology (1692) 1692
hepatitis b (1689) 1689
genetic aspects (1672) 1672
care and treatment (1635) 1635
rodents (1601) 1601
medical prognosis (1477) 1477
retrospective studies (1472) 1472
liver cirrhosis (1470) 1470
treatment outcome (1460) 1460
gene expression regulation, neoplastic (1448) 1448
aged, 80 and over (1414) 1414
hepatitis c virus (1414) 1414
development and progression (1410) 1410
medical research (1397) 1397
studies (1395) 1395
biochemistry & molecular biology (1391) 1391
liver neoplasms - etiology (1374) 1374
kinases (1372) 1372
metastases (1358) 1358
hepatitis b virus - genetics (1356) 1356
cancers and neoplasms (1323) 1323
signal transduction (1321) 1321
cell proliferation (1319) 1319
infection (1304) 1304
liver neoplasms - epidemiology (1301) 1301
risk (1251) 1251
gastroenterology and hepatology (1248) 1248
hepatitis c (1239) 1239
liver neoplasms - surgery (1234) 1234
mutation (1229) 1229
liver cirrhosis - virology (1224) 1224
genes (1208) 1208
liver neoplasms - drug therapy (1199) 1199
hepatitis b - complications (1198) 1198
carcinoma, hepatocellular - etiology (1195) 1195
chemotherapy (1193) 1193
liver - pathology (1193) 1193
biology (1184) 1184
diagnosis (1183) 1183
cancer therapies (1157) 1157
mortality (1138) 1138
pathology (1129) 1129
carcinoma, hepatocellular - epidemiology (1127) 1127
cells (1125) 1125
therapy (1122) 1122
immunohistochemistry (1121) 1121
liver neoplasms - mortality (1113) 1113
medicine and health sciences (1113) 1113
liver neoplasms - diagnosis (1102) 1102
virology (1072) 1072
disease progression (1063) 1063
immunology (1059) 1059
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18015) 18015
Chinese (276) 276
Japanese (131) 131
French (80) 80
Spanish (28) 28
Korean (16) 16
Hungarian (15) 15
Russian (15) 15
German (10) 10
Polish (8) 8
Italian (7) 7
Croatian (4) 4
Danish (3) 3
Dutch (3) 3
Portuguese (3) 3
Czech (2) 2
Turkish (2) 2
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oral Oncology, ISSN 1368-8375, 2013, Volume 49, Issue 1, pp. 79 - 85
Summary Objectives To describe the natural course of distant metastases (DMs) following radiotherapy (RT) or chemoradiotherapy (CRT) in HPV(+) oropharyngeal... 
Otolaryngology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Human papillomavirus | Oropharyngeal carcinoma | Radiotherapy | Chemoradiotherapy | SURVIVAL | HEAD | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | PHASE-III TRIAL | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | SQUAMOUS-CELL CARCINOMA | EPSTEIN-BARR-VIRUS | NECK-CARCINOMA | Oropharyngeal Neoplasms - therapy | Papillomavirus Infections - radiotherapy | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Carcinoma - virology | Salvage Therapy | Male | Papillomavirus Infections - therapy | Neoplasm Recurrence, Local - pathology | Lung Neoplasms - secondary | Tongue Neoplasms - virology | Aged, 80 and over | Adult | Female | Retrospective Studies | Tonsillar Neoplasms - therapy | Liver Neoplasms - secondary | Carcinoma - secondary | Tongue Neoplasms - radiotherapy | Liver Neoplasms - virology | Radiotherapy Dosage | Tongue Neoplasms - therapy | Alphapapillomavirus - classification | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Oropharyngeal Neoplasms - virology | Carcinoma - radiotherapy | Lung Neoplasms - virology | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - virology | Skin Neoplasms - virology | Skin Neoplasms - secondary | Carcinoma - therapy | Aged | Neoplasm Staging | Cohort Studies | Care and treatment | Metastasis | Nuclear radiation | Papillomavirus infections | Cancer
Journal Article
International journal of cancer, ISSN 1097-0215, 2008, Volume 123, Issue 1, pp. 187 - 194
Data are limited regarding cancer risk in human immunodeficiency virus (HIV)‐infected persons with modest immunosuppression, before the onset of acquired... 
HIV/AIDS | lung cancer | epidemiology | Kaposi sarcoma | non‐Hodgkin lymphoma | liver cancer | Hodgkin lymphoma | Non-Hodgkin lymphoma | Liver cancer | Lung cancer | Epidemiology | SQUAMOUS INTRAEPITHELIAL LESIONS | non-Hodgkin lymphoma | HUMAN-PAPILLOMAVIRUS | HODGKIN-LYMPHOMA | PREVALENCE | LUNG-CANCER | HEPATOCELLULAR-CARCINOMA | HIV-INFECTION | ONCOLOGY | ACTIVE ANTIRETROVIRAL THERAPY | COHORT | AIDS-DEFINING CANCERS | Hodgkin Disease - virology | Follow-Up Studies | HIV Infections - epidemiology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Child, Preschool | Infant | Male | Incidence | HIV Infections - immunology | Liver Neoplasms - epidemiology | Neoplasms - virology | Neoplasms - ethnology | Adult | Female | HIV Infections - transmission | Registries | Medical Record Linkage | Child | Colorado - epidemiology | Sarcoma, Kaposi - epidemiology | Infant, Newborn | Liver Neoplasms - virology | New Jersey - epidemiology | Florida - epidemiology | Lymphoma, Non-Hodgkin - virology | CD4 Lymphocyte Count | Hodgkin Disease - epidemiology | Sarcoma, Kaposi - virology | Lung Neoplasms - virology | Lymphoma, Non-Hodgkin - epidemiology | Antiretroviral Therapy, Highly Active | Lung Neoplasms - epidemiology | Adolescent | HIV Infections - complications | Uterine Cervical Neoplasms - virology | HIV Infections - drug therapy | Poisson Distribution | HIV Infections - ethnology | Neoplasms - epidemiology
Journal Article
British Journal of Hospital Medicine, ISSN 1750-8460, 10/2016, Volume 77, Issue 10, pp. 565 - 568
Virus infections are an important factor in the global burden of human cancer. The discovery and mode of action of human tumour viruses is briefly reviewed... 
IMMUNE-RESPONSE | MEDICINE, GENERAL & INTERNAL | SEQUENCES | VACCINATION | PREVENTION | HUMAN-PAPILLOMAVIRUS | CANCER | CARCINOMA | EPSTEIN-BARR-VIRUS | MERKEL CELL POLYOMAVIRUS | INSIGHTS | Viral Vaccines - therapeutic use | Leiomyosarcoma - virology | Carcinoma, Hepatocellular - prevention & control | Humans | Carcinoma - virology | Nasopharyngeal Neoplasms - virology | Male | Neoplasms - prevention & control | Epstein-Barr Virus Infections - prevention & control | Neoplasms - virology | Skin Neoplasms - prevention & control | Female | Hepatitis B virus | Liver Neoplasms - prevention & control | Liver Neoplasms - virology | Oncogenic Viruses | Stomach Neoplasms - virology | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Carcinoma - prevention & control | Carcinoma, Hepatocellular - virology | Tumor Virus Infections - prevention & control | Adenocarcinoma - virology | Herpesvirus 4, Human | Adenocarcinoma - prevention & control | Papillomavirus Infections - prevention & control | Lymphoma - prevention & control | Skin Neoplasms - virology | Stomach Neoplasms - prevention & control | Vulvar Neoplasms - prevention & control | Uterine Cervical Neoplasms - virology | Papillomaviridae | Nasopharyngeal Neoplasms - prevention & control | Leiomyosarcoma - prevention & control | Hepacivirus | Epidermodysplasia Verruciformis - prevention & control | Lymphoma - virology
Journal Article
Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 14, pp. 2642 - 2650
BACKGROUND Early‐stage and intermediate‐stage nasopharyngeal cancer (NPC) generally carry a good prognosis, but for patients with recurrent, metastatic... 
adoptive T‐cell immunotherapy | nasopharyngeal carcinoma | clinical trials | phase 1/2 | Epstein‐Barr virus | adoptive T-cell immunotherapy | Epstein-Barr virus | CARBOPLATIN | MANAGEMENT | COMBINATION | CHEMOTHERAPY | GEMCITABINE | PACLITAXEL | PATHOGENESIS | CYTOTOXIC T-CELLS | PHASE-II TRIAL | ONCOLOGY | LYMPHOCYTES | Bone Neoplasms - therapy | Humans | Middle Aged | Carcinoma - virology | Nasopharyngeal Neoplasms - virology | Neoplasm Recurrence, Local - virology | Bone Neoplasms - secondary | Male | Liver Neoplasms - therapy | Nasopharyngeal Neoplasms - secondary | Feasibility Studies | Nasopharyngeal Neoplasms - pathology | Young Adult | Neoplasm Metastasis | Flow Cytometry | Lung Neoplasms - secondary | T-Lymphocytes, Cytotoxic - transplantation | Adult | Female | Carcinoma - pathology | Liver Neoplasms - secondary | Carcinoma - secondary | T-Lymphocytes, Cytotoxic - immunology | Immunotherapy, Adoptive - methods | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Herpesvirus 4, Human - immunology | Enzyme-Linked Immunospot Assay | Lung Neoplasms - therapy | Disease Progression | Disease-Free Survival | Pilot Projects | Carcinoma - therapy | Aged | Chemotherapy | Usage | Care and treatment | Immunotherapy | Research | Nasopharyngeal cancer | Cancer | Antigens | Prognosis | Effectiveness | Adoptive immunotherapy | Cytotoxicity | Viruses | Lymphocytes T | Metastasis | Disease control | Patients | Survival | Metastases | Nasopharyngeal carcinoma | Antigen (tumor-associated) | Medical prognosis | Remission | Informed consent | Manufacturing
Journal Article
Annual review of medicine, ISSN 1545-326X, 2011, Volume 62, Issue 1, pp. 141 - 155
Although antiretroviral therapy for HIV infection prevents AIDS-related complications and prolongs life, it does not fully restore health. Long-term treated... 
CD28 | frailty | CD38 | CMV | telomere | MEDICINE, RESEARCH & EXPERIMENTAL | LIFE-SPAN | MYOCARDIAL-INFARCTION | ANTIRETROVIRAL THERAPY | CYTOMEGALOVIRUS-INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | REPLICATIVE SENESCENCE | REVERSE-TRANSCRIPTASE INHIBITORS | T-CELL RESPONSES | CALORIC RESTRICTION | IMMUNE ACTIVATION | Immune System - virology | Humans | Mitochondrial Diseases - immunology | T-Lymphocytes - virology | HIV Infections - immunology | Neoplasms - virology | Aging - immunology | Cardiovascular Diseases - virology | Aging - genetics | Anti-HIV Agents - therapeutic use | Metabolic Syndrome - immunology | Intra-Abdominal Fat - immunology | Intra-Abdominal Fat - virology | Liver Diseases - immunology | Liver Diseases - virology | Bone Diseases - virology | Mitochondrial Diseases - virology | Inflammation - virology | Treatment Outcome | Inflammation - immunology | Bone Diseases - immunology | Antiretroviral Therapy, Highly Active | Kidney Diseases - immunology | Cardiovascular Diseases - immunology | Neoplasms - immunology | HIV Infections - complications | Metabolic Syndrome - virology | HIV Infections - drug therapy | Kidney Diseases - virology | Nervous System Diseases - virology | T-Lymphocytes - immunology | Nervous System Diseases - immunology | Anti-HIV Agents - immunology | Prevention | Aging | Physiological aspects | Telomeres | Care and treatment | HIV infection
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 153, Issue 4, pp. 996 - 1005.e1
Abstract Background and Aims The risk of hepatocellular cancer (HCC) after sustained virological response (SVR) with direct acting antivirals (DAA) is unclear.... 
Gastroenterology and Hepatology | Therapy | Liver Cancer | Viral Hepatitis | Outcome | LONG-TERM | VETERANS | SUSTAINED VIROLOGICAL RESPONSE | LIVER-CANCER | HEPATITIS-C VIRUS | CIRRHOSIS | INFECTION | RECURRENCE | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | United States - epidemiology | Carcinoma, Hepatocellular - epidemiology | Hepatitis C - drug therapy | Carcinoma, Hepatocellular - prevention & control | Humans | Middle Aged | Male | Incidence | Protective Factors | Liver Cirrhosis - epidemiology | Liver Neoplasms - epidemiology | Time Factors | Female | Hepatitis C - complications | Retrospective Studies | Liver Neoplasms - prevention & control | Liver Neoplasms - virology | Liver Cirrhosis - prevention & control | Risk Assessment | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Carcinoma, Hepatocellular - virology | Tumor Burden | Hepatitis C - diagnosis | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Antiviral Agents - adverse effects | Aged | Sustained Virologic Response | Neoplasm Staging | Hospitals, Veterans | Antiviral agents | Care and treatment | Continuing medical education | Cancer patients | Hepatitis C virus | Hepatitis C | Health aspects | Risk factors | Cancer | Medical research | Medicine, Experimental | Liver cirrhosis
Journal Article
International Journal of Clinical and Experimental Pathology, ISSN 1936-2625, 2014, Volume 7, Issue 5, pp. 2421 - 2429
Inflammatory pseudotumor (IPT)-like follicular dendritic cell (FDC) sarcoma is a recently described rare tumor and considered a unique entity, with different... 
Spleen | Epstein-Barr virus | Follicular dendritic cell sarcoma | Inflammatory pseudotumor | Liver | NEOPLASMS | spleen | liver | TUMOR | CLUSTERIN | PROLIFERATION | PATHOLOGY | ENTITY | ONCOLOGY | LYMPH-NODE | inflammatory pseudotumor | EXPRESSION | EPSTEIN-BARR-VIRUS | Immunohistochemistry | Predictive Value of Tests | Herpesvirus 4, Human - genetics | Granuloma, Plasma Cell - mortality | Humans | Middle Aged | Liver Neoplasms - complications | Male | Liver Neoplasms - chemistry | Liver Neoplasms - mortality | Hepatectomy | Splenic Neoplasms - mortality | Splenectomy | Neoplasm Metastasis | In Situ Hybridization | Time Factors | Splenic Neoplasms - complications | Female | Liver Neoplasms - pathology | Dendritic Cell Sarcoma, Follicular - surgery | Liver Neoplasms - virology | Abdominal Pain - etiology | Granuloma, Plasma Cell - virology | Biomarkers, Tumor - analysis | Risk Factors | Neoplasm Recurrence, Local | Dendritic Cells, Follicular - virology | Liver Neoplasms - surgery | Treatment Outcome | Splenic Neoplasms - virology | Splenic Neoplasms - chemistry | Dendritic Cell Sarcoma, Follicular - virology | Dendritic Cell Sarcoma, Follicular - complications | Dendritic Cell Sarcoma, Follicular - pathology | Granuloma, Plasma Cell - pathology | Splenic Neoplasms - surgery | Dendritic Cells, Follicular - chemistry | Granuloma, Plasma Cell - surgery | Splenic Neoplasms - pathology | Biopsy | Dendritic Cells, Follicular - pathology | Aged | Dendritic Cell Sarcoma, Follicular - mortality | Granuloma, Plasma Cell - metabolism | DNA, Viral - genetics | Dendritic Cell Sarcoma, Follicular - metabolism | Granuloma, Plasma Cell - complications
Journal Article
Journal Article
Survey of Ophthalmology, ISSN 0039-6257, 2008, Volume 53, Issue 4, pp. 312 - 331
Abstract Given the fact that infectious agents contribute to around 18% of human cancers worldwide, it would seem prudent to explore their role in neoplasms of the ocular adnexa... 
Ophthalmology | Kaposi sarcoma | human herpes simplex virus-8 (HHV-8) | MALT lymphoma | papilloma | Helicobacter pylori (H. pylori) | Chlamydia psittaci (C. psittaci) | ocular adnexa | human papilloma virus (HPV) | squamous cell carcinoma | ACQUIRED-IMMUNODEFICIENCY-SYNDROME | SARCOMA-ASSOCIATED HERPESVIRUS | HUMAN-PAPILLOMAVIRUS DNA | LYMPHOID-TISSUE LYMPHOMA | POLYMERASE-CHAIN-REACTION | RECURRENT CONJUNCTIVAL PAPILLOMA | HELICOBACTER-PYLORI INFECTION | C VIRUS-INFECTION | SQUAMOUS-CELL CARCINOMA | OPHTHALMOLOGY | NON-HODGKINS-LYMPHOMA | Alphapapillomavirus - physiology | Conjunctival Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Eyelid Neoplasms - virology | Alphapapillomavirus - isolation & purification | Herpesvirus 8, Human - isolation & purification | Orbital Neoplasms - microbiology | Eye Infections, Bacterial - microbiology | HIV-1 - physiology | HIV-1 - isolation & purification | Lymphoma, B-Cell, Marginal Zone - virology | Hepacivirus - physiology | Conjunctival Neoplasms - microbiology | Eye Infections, Viral - pathology | Eye Infections, Bacterial - pathology | Herpesvirus 8, Human - physiology | Eye Neoplasms - virology | Hepacivirus - isolation & purification | Lacrimal Apparatus Diseases - microbiology | Eye Infections, Viral - virology | Chlamydophila psittaci - isolation & purification | Sarcoma, Kaposi - virology | Eyelid Neoplasms - microbiology | Chlamydophila psittaci - physiology | Orbital Neoplasms - virology | Eye Neoplasms - microbiology | Helicobacter pylori - isolation & purification | Helicobacter pylori - physiology | Lacrimal Apparatus Diseases - virology | Squamous cell carcinoma | Sarcoma | University and college libraries | Development and progression | HIV (Viruses) | Diseases | Liver cancer | Chemotherapy | Analysis | Lymphomas | Hepatitis C | Papillomavirus infections | Causes and theories of causation | Cervical cancer | Cancer
Journal Article